Concepedia

Savita Lochab

SL

Statistics

Publications

12

Citations

385

H-Index

12

Active since

2010

Affiliations

Central Drug Research Institute(Current)

University Hospital Leipzig

King George's Medical University

National Institute of Immunology

Savita Lochab is an author at Central Drug Research Institute specializing in life sciences, molecular biology, and cell biology.

ORCID

Publications per year

2010–2020

12

Publications

12

Synthesis and cytotoxicity evaluation of (tetrahydro-β-carboline)-1,3,5-triazine hybrids as anticancer agents

Ravi Ranjan Kumar, Leena Gupta, Pooja Pal et al. · European Journal of Medicinal Chemistry · 2010 · 71 citations

, , +9

Skp2 inhibits osteogenesis by promoting ubiquitin–proteasome degradation of Runx2

Gatha Thacker, Yogesh Kumar, Mohd Parvez Khan et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2016 · 50 citations

, , +12

2‐D gel electrophoresis‐based proteomic analysis reveals that ormeloxifen induces G0–G1 growth arrest and ERK‐mediated apoptosis in chronic myeloid leukemia cells K562

Pooja Pal, Jitendra Kumar Kanaujiya, Savita Lochab et al. · PROTEOMICS · 2011 · 37 citations

, , +17

E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation

Savita Lochab, Pooja Pal, Isha Kapoor et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2013 · 35 citations

, , +11

E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation

Pooja Pal, Savita Lochab, Jitendra Kumar Kanaujiya et al. · Cell Death and Disease · 2013 · 34 citations · Full text

, , +13

1–5 of 12